FDA
approval
· 2026-03-31
FDA Approved: MESALAMINE — Original Application (KLM Laboratories Private Limited)
Summary
FDA approved KLM Laboratories Private Limited's mesalamine generic under an Original Application (ANDA 220016) for the treatment of ulcerative colitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for MESALAMINE (MESALAMINE)